Source: Eur Respir J 2006 Oct 01;28(4):824-831
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Ye Q., Chen B., Tong Z., Nakamura S., Sarria R., Costabel U., Guzman J.. Thalidomide reduces IL-18, IL-8 and TNF-α release from alveolar macrophages in interstitial lung disease. Eur Respir J 2006 Oct 01;28(4):824-831

Member's Comments

No comment yet.

Related content which might interest you: Effect of nintedanib on the release of angiogenic/angiostatic cytokines by alveolar macrophages (AMs) in interstitial lung diseases (ILD) Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 N-acetylcysteine reduces tumor necrosis factor-α release by alveolar macrophages of interstitial lung disease in vitro Source: Annual Congress 2007 - Considerations in the therapeutic approach of interstitial lung disease: oxidative stress and inflammation Year: 2007 M2 polarized alveolar macrophages in pulmonary fibrosis Source: Annual Congress 2005 - Pulmonary hypertension and fibrosis: novel mechanisms Year: 2005 Alveolar macrophage oxidative and pro-inflammatory cytokine activity in lung sarcoidosis Source: Eur Respir J 2005; 26: Suppl. 49, 332s Year: 2005 Raised interleukin-17 is immunolocalised to neutrophils in cystic fibrosis lung disease Source: Eur Respir J 2011; 37: 1378-1385 Year: 2011 HGF and IL-6 in BAL fluid of interstitial lung diseases: effect on human lung fibroblasts Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease Year: 2008 Azithromycin increases phagocytosis of apoptotic bronchial epithelial cells by alveolar macrophages Source: Eur Respir J 2006; 28: 486-495 Year: 2006 β-Adrenoceptor stimulation and neutrophil accumulation in mouse airways Source: Eur Respir J 2004; 24: 231-237 Year: 2004 The production of IL-18, IL-12 and TNF-alpha by alveolar macrophages in sarcoidosis and hypersensitivity pneumonitis Source: Eur Respir J 2003; 22: Suppl. 45, 177s Year: 2003 Increased production of caspase-1 by alveolar macrophages in patients with pulmonary sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 585s Year: 2002 A role of GM-CSF in the accumulation of neutrophils in the airways caused by IL-17 and TNF-α Source: Eur Respir J 2003; 21: 387-393 Year: 2003 Relationship between IL-8, IL-10, MMP-9 and morphological findings in BAL fluid of patients with interstitial lung diseases Source: Eur Respir J 2003; 22: Suppl. 45, 225s Year: 2003 Oxidative burst in lipopolysaccharide-activated human alveolar macrophages is inhibited by interleukin-9 Source: Eur Respir J 2002; 20: 1198-1205 Year: 2002 The effect of pentoxifylline on IL-12 and IL-18 release by alveolar macrophages in sarcoidosis and hypersensitivity pneumonitis versus idiopathic pulmonary fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 377s Year: 2003 Alveolar macrophages and CC chemokines are increased in children with cystic fibrosis Source: Eur Respir J 2009; 34: 655 Year: 2009 CTGF and TNFa expression in alveolar macrophages of patients with idiopathic pulmonary fibrosis before and after treatment with azathioprine and interferon-g Source: Annual Congress 2009 - Idiopathic pulmonary fibrosis: concepts and mechanisms Year: 2009 Effect of pirfenidone (PFD) on cytokine/chemokine release from alveolar macrophages (AMs) in interstitial lung diseases (ILD): Preliminary results Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 Resveratrol impairs the release of steroid-resistant cytokines from bacterial endotoxin-exposed alveolar macrophages (AM) in COPD Source: Annual Congress 2011 - Experimental modulation of airway inflammation Year: 2011 α1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients Source: Eur Respir J 2007; 29: 240-250 Year: 2007 Eosinophil cationic protein stimulates TGF-β1 release by human lung fibroblasts Source: Annual Congress 2005 - Inflammation and remodelling in allergy and asthma Year: 2005